(Q55474428)

English

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma. (English)

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

medulloblastoma

0 references

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Vassal G

1

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Tranchand B

2

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Valteau-Couanet D

3

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Mahé C

4

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Couanet D

5

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Schoeppfer C

6

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Grill J

7

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Kalifa C

8

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Hill C

9

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Ardiet C

10

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Hartmann O

11

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Bone Marrow Transplantation

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

27

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

5

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

471-477

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702806

0 references

High-dose intravenous melphalan: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Some suggestions for measuring predictive performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

21 January 2018

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of high-dose melphalan in children and adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of oral melphalan in recurrent primary brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan dosage adjustment: possibility of using a test-dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702806

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702806

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 July 2018

http://europepmc.org/abstract/MED/11313680

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55474428&oldid=2144105863"